JPMorgan Chase & Co. Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

JPMorgan Chase & Co. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 206.3% during the third quarter, Holdings Channel.com reports. The fund owned 1,847,389 shares of the medical instruments supplier’s stock after purchasing an additional 1,244,326 shares during the quarter. JPMorgan Chase & Co.’s holdings in DENTSPLY SIRONA were worth $49,990,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. First Eagle Investment Management LLC boosted its holdings in DENTSPLY SIRONA by 33.6% in the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares in the last quarter. Nuance Investments LLC raised its stake in DENTSPLY SIRONA by 3.8% in the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after buying an additional 402,329 shares in the last quarter. FMR LLC lifted its holdings in DENTSPLY SIRONA by 5.1% in the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after buying an additional 436,031 shares during the period. Dimensional Fund Advisors LP boosted its position in DENTSPLY SIRONA by 42.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after acquiring an additional 1,308,411 shares in the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of DENTSPLY SIRONA by 7.8% during the 2nd quarter. American Century Companies Inc. now owns 2,482,953 shares of the medical instruments supplier’s stock worth $61,850,000 after acquiring an additional 179,119 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $18.62 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $37.60. The firm has a market capitalization of $3.70 billion, a price-to-earnings ratio of -9.00, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The firm has a 50 day moving average of $19.64 and a 200 day moving average of $23.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the previous year, the firm posted $0.49 EPS. The company’s revenue for the quarter was up .4% compared to the same quarter last year. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.44%. DENTSPLY SIRONA’s payout ratio is currently -30.92%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on XRAY. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Finally, Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Eight investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus price target of $27.91.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.